Abstract

Elite controllers (EC) represent a small subset of HIV-1-infected people that spontaneously control viral replication. However, natural virological suppression and absence of immune dysfunction are not always long-term sustained. We define exceptional EC (EEC) as HIV-1 subjects who maintain the EC characteristics without disease progression for more than 25 years. We analyzed three EEC, diagnosed between 1988 and 1992, who never showed signs of clinical disease progression in absence of any antiretroviral treatment. A comprehensive clinical, virological, and immunological study was performed. The individuals simultaneously exhibited ≥3 described host protective alleles, low levels of total HIV-1 DNA (<20 copies/106 CD4+ T-cells) without evidence of replication-competent viruses (<0.025 IUPM), consistent with high levels of defective genomes, strong cellular HIV-1-specific immune response, and a high poly-functionality index (>0.50). Inflammation levels of EEC were similar to HIV-1 negative donors. Remarkably, they showed an exceptional lack of viral evolution and 8-fold lower genetic diversity (<0.01 s/n) in env gene than other EC. We postulate that these EEC represent cases of spontaneous functional HIV-1 cure. A non-functional and non-genetically evolving viral reservoir along with an HIV-1-specific immune response seems to be key for the spontaneous functional cure.

Details

Title
Permanent control of HIV-1 pathogenesis in exceptional elite controllers: a model of spontaneous cure
Author
Casado Concepcion 1 ; Galvez, Cristina 2 ; Pernas, Maria 1 ; Tarancon-Diez Laura 3 ; Rodriguez, Carmen 4 ; Sanchez-Merino, Víctor 5 ; Mar, Vera 4 ; Olivares, Isabel 1 ; De Pablo-Bernal Rebeca 3 ; Merino-Mansilla, Alberto 5 ; Del Romero Jorge 4 ; Lorenzo-Redondo, Ramon 6 ; Ruiz-Mateos, Ezequiel 7 ; Salgado María 8 ; Martinez-Picado, Javier 9 ; Lopez-Galindez Cecilio 1 

 Virología Molecular, Laboratorio de Referencia e Investigación en Retrovirus, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, Spain (GRID:grid.413448.e) (ISNI:0000 0000 9314 1427) 
 AIDS Research Institute IrsiCaixa, Badalona, Spain (GRID:grid.413448.e); Universitat Autònoma de Barcelona, Cerdanyola del Vallès, Spain (GRID:grid.7080.f) 
 Clinical Unit of Infectious Diseases, Microbiology and Preventive Medicine, Institute of Biomedicine of Seville (IBiS), Virgen del Rocío University Hospital, CSIC, University of Seville, Seville, Spain (GRID:grid.413448.e) 
 Centro Sanitario Sandoval, Hospital Clínico San Carlos. IdISSC, Madrid, Spain (GRID:grid.413448.e) 
 AIDS Immunopathology Unit. Laboratorio de Referencia e Investigación en Retrovirus. Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, Spain (GRID:grid.413448.e) (ISNI:0000 0000 9314 1427) 
 Division of Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, USA (GRID:grid.16753.36) (ISNI:0000 0001 2299 3507) 
 Clinical Unit of Infectious Diseases, Microbiology and Preventive Medicine, Institute of Biomedicine of Seville (IBiS), Virgen del Rocío University Hospital, CSIC, University of Seville, Seville, Spain (GRID:grid.16753.36) 
 AIDS Research Institute IrsiCaixa, Badalona, Spain (GRID:grid.16753.36) 
 AIDS Research Institute IrsiCaixa, Badalona, Spain (GRID:grid.16753.36); University of Vic-Central University of Catalonia (UVic-UCC), Vic, Spain (GRID:grid.440820.a); Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain (GRID:grid.425902.8) (ISNI:0000 0000 9601 989X) 
Publication year
2020
Publication date
2020
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2351473347
Copyright
This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.